Ibio earnings were -$33.0M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest IBIO earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$10.6M, up 37.1% from last quarter. For the last reported fiscal year 2026 ending Jun 30, 2026, IBIO reported annual earnings of -$33.0M, with 79.8% growth. The next IBIO earnings date is Nov 11, 2026.
On IBIO's earnings call on Sep 4, 2026, Ibio (NASDAQ: IBIO) reported Q2 2026 earnings per share (EPS) of -$0.07, up 77.42% year over year. Total IBIO earnings for the quarter were -$10.60 million. In the same quarter last year, Ibio's earnings per share (EPS) was -$0.31.
The next IBIO earnings call is Nov 11, 2026. Add IBIO to your watchlist to be reminded of Ibio's next earnings date.
Is Ibio profitable or losing money?
As of the last Ibio earnings report, Ibio is currently losing money. Ibio's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$33.04 million, a 79.81% increase year over year.
What was IBIO's earnings growth in the past year?
As of Ibio's earnings date in Sep 4, 2026, Ibio's earnings has grown year over year. IBIO earnings in the past year totalled -$33.04 million.
What are Ibio's earnings expectations?
The current EPS estimate for Ibio's earnings report in Nov 11, 2026 is -$0.07.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.